Frontlight ResearchEarly access
Taking people in United StatesPhase 3
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
Key facts
- Who runs it
- Hospital for Special Surgery, New York
- Where
- New York, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 3
- People taking part
- 150 people, planned
- Started
- 5 Nov 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Depo-Medrol 40Mg/Ml Suspension for Injection
- Placebo
- Record updated
- 28 April 2026
Who can take part
- Age
- 18 years to 85 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients scheduled to undergo 1 to 2 level laminectomy
- Between the ages of 18-85
Who cannot take part
- Minimally invasive surgery
- Prior daily opioid usage within 6 months
- Use of concomitant procedures such as spinal fusion, revision procedure at the same level
- History of a chronic pain syndrome, uncontrolled diabetes defined as A1C > 6.5, immunocompromised condition such as active cancer treatment, history of transplant, benign prostatic hyperplasia or history of urinary retention, and other conditions which require chronic steroid therapy or immunosuppressants
- Patients allergic to Depo-Medrol and/or glucocorticoids, or other steroids
- Non-English speakers
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
This trial is currently available in United States.
- Hospital for Special SurgeryNew York, United StatesContact: Matthew Cunningham, MD, PhDTaking people
About the trial
What the trial wants to find out
This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
The 2 groups in the trial
- Group 1: Topical SteroidTreatment being tested
Treatment: Depo-Medrol 40Mg/Ml Suspension for Injection
- Group 2: Topical Normal SalinePlacebo, for comparison
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Topical Epidural Steroid Usage in Patients Undergoing Posterior Lumbar Decompression: A Randomized Control Trial
- Criteria questions
- Built from NCT05058287, who can take part
- Record updated
- 28 April 2026